Mastocytosis: molecular mechanisms and clinical disease heterogeneity
- 22 May 2001
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 25 (7) , 577-582
- https://doi.org/10.1016/s0145-2126(01)00046-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- MASTOCYTOSIS AND THE SKINHematology/Oncology Clinics of North America, 2000
- Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosisExperimental Hematology, 2000
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- The kit ligand: A cell surface molecule altered in steel mutant fibroblastsCell, 1990
- Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble formsCell, 1990
- Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel allelesCell, 1990
- Analysis of plasma histamine levels in patients with mast cell disordersThe American Journal of Medicine, 1989
- The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogeneCell, 1988
- The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locusNature, 1988